{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:15:03Z","timestamp":1784679303413,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T00:00:00Z","timestamp":1423267200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12936-015-0557-y","type":"journal-article","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T05:01:05Z","timestamp":1423198865000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali"],"prefix":"10.1186","volume":"14","author":[{"given":"Hamma","family":"Maiga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoulaye A","family":"Djimde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdoul H","family":"Beavogui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ousmane","family":"Toure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamadou","family":"Tekete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheick Papa O","family":"Sangare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Dara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoumana I","family":"Traore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oumar B","family":"Traore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souleymane","family":"Dama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"N\u2019Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidou","family":"Niangaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouhoum","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demba","family":"Dembele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issaka","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogobara K","family":"Doumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,7]]},"reference":[{"key":"557_CR1","first-page":"506","volume":"64","author":"H Sangho","year":"2004","unstructured":"Sangho H, Diawara A, Diallo M, Sow S, Sango HA, Sacko M, et al. Assessment of chloroquine resistance two years after stopping chemoprophylaxis in 0 to 9-year-old children living in a malaria-endemic village of Mali](in French). Med Trop (Mars). 2004;64:506\u201310.","journal-title":"Med Trop (Mars)"},{"key":"557_CR2","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.trstmh.2006.03.004","volume":"100","author":"X De Radigues","year":"2006","unstructured":"De Radigues X, Diallo KI, Diallo M, Ngwakum PA, Maiga H, Djimde A, et al. Efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Koumantou, Mali. Trans R Soc Trop Med Hyg. 2006;100:1013\u20138.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"557_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1574-695X.2009.00641.x","volume":"58","author":"AA Djimde","year":"2010","unstructured":"Djimde AA, Barger B, Kone A, Beavogui AH, Tekete M, Fofana B, et al. A molecular map of chloroquine resistance in Mali. FEMS Immunol Med Microbiol. 2010;58:113\u20138.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"557_CR4","volume-title":"WHO\/HTM\/MAL \/2005.1102","author":"WHO and UNICEF","year":"2005","unstructured":"WHO and UNICEF. World malaria report 2005. In: WHO\/HTM\/MAL \/2005.1102. Geneva: World Health Organization; 2005."},{"key":"557_CR5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4269\/ajtmh.2008.78.455","volume":"78","author":"AA Djimd\u00e9","year":"2008","unstructured":"Djimd\u00e9 AA, Fofana B, Sagara I, Sidibe B, Toure S, Dembele D, et al. Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali. Am J Trop Med Hyg. 2008;78:455\u201361.","journal-title":"Am J Trop Med Hyg"},{"key":"557_CR6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4269\/ajtmh.2006.75.630","volume":"75","author":"I Sagara","year":"2006","unstructured":"Sagara I, Dicko A, Djimde A, Guindo O, Kone M, Tolo Y, et al. A randomized trial of Artesunate-sulfamethoxypyrazine pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali. Am J Trop Med Hyg. 2006;75:630\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"557_CR7","unstructured":"WHO. Resistance to artemisinin derivatives along the Thai-Cambodian border. Wkly Epidemiology Rec. 2007;82:360."},{"key":"557_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"557_CR9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"557_CR10","unstructured":"Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, et al.. Independent emergence of Plasmodium falciparum artemisinin resistance mutations in Southeast Asia. J Infect Dis. 2014. [Epub ahead of print]"},{"key":"557_CR11","unstructured":"WHO Geneva 2001. who.int\/hq\/2001\/WHO_CDS_RBM_2001.35"},{"key":"557_CR12","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1086\/498249","volume":"192","author":"MA Thera","year":"2005","unstructured":"Thera MA, Sehdev PS, Coulibaly D, Traore K, Garba MN, Cissoko Y, et al. Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. J Infect Dis. 2005;192:1823\u20139.","journal-title":"J Infect Dis"},{"key":"557_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.actatropica.2007.04.005","volume":"102","author":"K Kayentao","year":"2007","unstructured":"Kayentao K, Mungai M, Parise M, Kodio M, Keita AS, Coulibaly D, et al. Assessing malaria burden during pregnancy in Mali. Acta Trop. 2007;102:106\u201312.","journal-title":"Acta Trop"},{"key":"557_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1475-2875-8-34","volume":"8","author":"M Tekete","year":"2009","unstructured":"Tekete M, Djimde AA, Beavogui AH, Maiga H, Sagara I, Fofana B, et al. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali. Malar J. 2009;8:34.","journal-title":"Malar J"},{"key":"557_CR15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4269\/ajtmh.1996.55.467","volume":"55","author":"CV Plowe","year":"1996","unstructured":"Plowe CV, Djimde A, Wellems TE, Kouriba B, Doumbo OK. Community pyrimethamine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance. Am J Trop Med Hyg. 1996;55:467\u201371.","journal-title":"Am J Trop Med Hyg"},{"key":"557_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/1475-2875-7-205","volume":"7","author":"N Sogoba","year":"2008","unstructured":"Sogoba N, Vounatsou P, Bagayoko MM, Doumbia S, Dolo G, Gosoniu L, et al. Spatial distribution of the chromosomal forms of Anopheles gambiae in Mali. Malar J. 2008;7:205.","journal-title":"Malar J"},{"key":"557_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1086\/430707","volume":"41","author":"DA Diallo","year":"2005","unstructured":"Diallo DA, Doumbo OK, Plowe CV, Wellems TE, Emanuel EJ, Hurst SA. Community permission for medical research in developing countries. Clin Infect Dis. 2005;41:255\u20139.","journal-title":"Clin Infect Dis"},{"key":"557_CR18","volume-title":"Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated malaria","author":"WHO","year":"2003","unstructured":"WHO. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated malaria. Geneva: World Health Organization; 2003."},{"key":"557_CR19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4269\/ajtmh.2003.69.253","volume":"69","author":"KE Lyke","year":"2003","unstructured":"Lyke KE, Diallo DA, Dicko A, Kone A, Coulibaly D, Guindo A, et al. Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations, and prognosis in severe malaria. Am J Trop Med Hyg. 2003;69:253\u20139.","journal-title":"Am J Trop Med Hyg"},{"key":"557_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJM200101253440403","volume":"344","author":"A Djimde","year":"2001","unstructured":"Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourt\u00e9 Y, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med. 2001;344:257\u201363.","journal-title":"N Engl J Med"},{"key":"557_CR21","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/0022-2836(87)90649-8","volume":"195","author":"K Tanabe","year":"1987","unstructured":"Tanabe K, Mackey M, Goman M, Scaife J. Allelic dimorphic in a surface antigen gene of P. falciparum. J Mol Biol. 1987;195:273\u201387.","journal-title":"J Mol Biol"},{"key":"557_CR22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0035-9203(97)90539-3","volume":"91","author":"LC Ranford-Cartwright","year":"1997","unstructured":"Ranford-Cartwright LC, Taylor J, Umasunthar T, Taylor LH, Babiker HA, Lell B, et al. Molecular analysis of recrudescent parasites in a Plasmodium falciparum drug efficacy trial in Gabon. Trans R Soc Trop Med Hyg. 1997;91:719\u201324.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"557_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1475-2875-8-5","volume":"8","author":"K Kayentao","year":"2009","unstructured":"Kayentao K, Maiga H, Newman R, McMorrow LM, Hoppe A, Yattara O, et al. Artemisinin-based combinations versus amodiaquine plus sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje. Mali Malar J. 2009;8:5.","journal-title":"Mali. Malar J"},{"key":"557_CR24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4269\/ajtmh.2003.68.743","volume":"68","author":"CE Rwagacondo","year":"2003","unstructured":"Rwagacondo CE, Niyitegeka F, Sarushi J, Karema C, Mugsha V, Dujardin JC, et al. Efficacy of amodiaquine alone and combined with sulphadoxine-pyrimethamine and of sulphadoxine-pyrimethamine combined with artesunate. Am J Trop Med Hyg. 2003;68:743\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"557_CR25","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2165\/00003088-199630040-00002","volume":"30","author":"S Krishna","year":"1996","unstructured":"Krishna S, White NJ. Pharmacokinetics of quinine, chloroquine and amodiaquine Clinical implications. Clin Pharmacokinet. 1996;30:263\u201399.","journal-title":"Clin Pharmacokinet"},{"key":"557_CR26","first-page":"860","volume":"13","author":"EANMAT","year":"2003","unstructured":"EANMAT. The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. Trop Med Int Health. 2003;13:860\u20137.","journal-title":"Trop Med Int Health"},{"key":"557_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1475-2875-6-146","volume":"6","author":"AM Kabanywanyi","year":"2007","unstructured":"Kabanywanyi AM, Mwita A, Sumari D, Mandike R, Mugittu K, Abdulla S. Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania. Malar J. 2007;6:146.","journal-title":"Malar J"},{"key":"557_CR28","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4269\/ajtmh.2007.77.612","volume":"13","author":"S Rulisa","year":"2007","unstructured":"Rulisa S, Gatarayiha JP, Kabarisa T, Ndayisaba G. Comparison of different artemisinin-based combinations for the treatment of Plasmodium falciparum malaria in children in Kigali, Rwanda, an area of resistance to sulfadoxine-pyrimethamine: artesunate plus sulfadoxine\/pyrimethamine versus artesunate plus sulfamethoxypyrazine\/pyrimethamine. Am J Trop Med Hyg. 2007;13:612\u20136.","journal-title":"Am J Trop Med Hyg"},{"key":"557_CR29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1475-2875-13-9","volume":"13","author":"D Djall\u00e9","year":"2014","unstructured":"Djall\u00e9 D, Njuimo SP, Manirakiza A, Laganier R, Le Faou A, Rogier C. Efficacy and safety of artemether\u2009+\u2009lumefantrine, artesunate\u2009+\u2009sulphamethoxypyrazine-pyrimethamine and artesunate\u2009+\u2009amodiaquine and sulphadoxine-pyrimethamine\u2009+\u2009amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial. Malar J. 2014;13:9.","journal-title":"Malar J"},{"key":"557_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1475-2875-9-34","volume":"9","author":"WF Mbacham","year":"2010","unstructured":"Mbacham WF, Evehe MS, Netongo PM, Ateh IA, Mimche PN, Ajua A, et al. Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy. Malar J. 2010;9:34.","journal-title":"Malar J"},{"key":"557_CR31","doi-asserted-by":"publisher","first-page":"e1000408","DOI":"10.1371\/journal.pmed.1000408","volume":"8","author":"AT Konat\u00e9","year":"2011","unstructured":"Konat\u00e9 AT, Yaro JB, Ou\u00e9draogo AZ, Diarra A, Gansan\u00e9 A, Soulama I, et al. Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomized, double blind, and placebo controlled trial. PLoS Med. 2011;8:e1000408.","journal-title":"PLoS Med"},{"key":"557_CR32","doi-asserted-by":"publisher","first-page":"e23390","DOI":"10.1371\/journal.pone.0023390","volume":"6","author":"A Dicko","year":"2011","unstructured":"Dicko A, Barry A, Dicko M, Diallo AI, Tembine I, Dicko Y, et al. Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial. PLoS ONE. 2011;6:e23390.","journal-title":"PLoS ONE"},{"key":"557_CR33","unstructured":"World Health Organization (2012). WHO Policy Recommendation: Seasonal Malaria Chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. March 2012. http:\/\/www.who.int\/malaria\/publications\/atoz\/mpac_report_february_2012\/en\/"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0557-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-015-0557-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0557-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0557-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T08:11:15Z","timestamp":1630570275000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-015-0557-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,7]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1186\/s12936-015-0557-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,7]]},"assertion":[{"value":"9 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"64"}}